NCT06743035 2026-01-09
ROPE
iOMEDICO AG
Recruiting
Clinical Trials
5 trialsNCT05548062 2025-09-03
Prospero
Novartis
Active not recruiting
NCT05853445 2024-05-06
PAVE
Novartis
Completed
NCT05421104 2022-07-05
Ruxolitinib for Polycythemia Vera in Patients Resistant to or Intolerant of Hydroxyurea.
Novartis
Completed
NCT02252159 2021-04-26
Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)
Incyte Corporation
Completed